| # | Drug | Count |
|---|---|---|
| 0 | DROSPIRENONE AND ETHINYL ESTRADIOL | 63 |
| 1 | CYCLOPHOSPHAMIDE | 28 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 28 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 28 |
| 4 | CISPLATIN | 23 |
| 5 | PREDNISONE | 23 |
| 6 | TRASTUZUMAB | 22 |
| 7 | FLUOROURACIL | 21 |
| 8 | FLUOROURACIL CREAM, 0.5% | 21 |
| 9 | DOCETAXEL | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEMIN | 2 | 0.0034 |
| 1 | CALAMINE | 1 | 0.0023 |
| 2 | FERRIC OXIDE RED | 1 | 0.0022 |
| 3 | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | 4 | 0.0022 |
| 4 | DICLOXACILLIN SODIUM | 2 | 0.0022 |
| 5 | ARGATROBAN | 3 | 0.0020 |
| 6 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 7 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 8 | DROSPIRENONE AND ETHINYL ESTRADIOL | 63 | 0.0014 |
| 9 | NAFCILLIN SODIUM | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 61 |
| 1 | Platinum-based Drug [EPC] | 44 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 40 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 4 | Alkylating Drug [EPC] | 32 |
| 5 | Microtubule Inhibitor [EPC] | 29 |
| 6 | Proton Pump Inhibitor [EPC] | 28 |
| 7 | Benzodiazepine [EPC] | 27 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 22 |
| 9 | Vitamin C [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 5 | 0.0027 |
| 1 | Human C1 Esterase Inhibitor [EPC] | 4 | 0.0010 |
| 2 | Anti-coagulant [EPC] | 3 | 0.0008 |
| 3 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 4 | Asparagine-specific Enzyme [EPC] | 7 | 0.0005 |
| 5 | Actinomycin [EPC] | 1 | 0.0005 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 22 | 0.0003 |
| 8 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 9 | Potassium-sparing Diuretic [EPC] | 3 | 0.0002 |